Abstract. The large circular (LC)-antisense library to the 221 unigene clone was constructed and utilized in the identification of genes functionally involved in the growth of hepatocellular carcinoma cells. We identified that 37 out of the 221 members of the antisense library exerted a marked inhibitory effect on the growth of Huh-7. The putative functional categorization of each gene was then conducted on the basis of the sequence information. The relative expression levels of target genes were measured and treated with two LC-antisense molecules by real-time PCR. LC-antisense to EIF3EIP and AFP abolished the expression of EIF3EIP and AFP to the level of ~7 and 39% compared to the control treatment in Huh-7 cells, respectively. LC-antisense molecules to EIF3EIP and AFP were simultaneously treated with 5-FU to Huh-7 cells. Two LC-antisense molecules showed additive effects with 5-FU compared with 5-FU alone, respectively. The combination of LC-antisense molecules and 5-FU showed a dramatic increase of sub-G1 apoptotic cell death fraction in cell cycle analysis, respectively. Therefore, these candidates may be used as target genes for drug development or adjuvant of conventional chemotherapeutic drugs.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor in the world (1) . Although complete surgical resection is the potential curative therapy, the chances for resection are not enough (2) . Liver transplantation is the only definite treatment for both HCC and the underlying liver disease (3) . However, the paucity of organs for transplantation is another problem. HCC is a type of tumor, which is highly resistant to available chemotherapeutic agents, administered either alone or in combination (4) . Since most of the antineoplastic medications are at least partially metabolized in the liver, patients with an underlying disease such as cirrhosis have a narrow therapeutic window. Thus, up to 25% of patients with HCC receive no effective therapy at all (5) . There is a strong need to investigate the mechanisms of carcinogenesis, invasion and metastasis of HCC for new therapeutic modality.
Various methods have been devised to study the expression of a large number of genes, generating a vast amount of information (6) . However, this rapid accumulation of genomic sequence information and expression profiling has created a bottleneck in subsequent definitive gene functionalization and/or target validation. Most definitive functionalization of genes has been performed with various conventional gain-offunction or loss-of-function studies. Recently, it has been thought that cell-based array using transfection indeed paved the way for loss-of-function experiments (7) . Effects of gene silencing on this platform can be monitored by using downstream signaling events, apoptosis and other cellular processes. With the increase in genomic and proteomic databases, gene-silencing libraries may characterize genes involved in cancer development and progression (8) . Lossof-function has been performed either with gene knockdown using conventional antisense and RNA interference technique, or with gene knockout using homologous recombination. The construction of an extensive antisense library may provide an answer to this information bottleneck for massive gene functionalization. Recently, high-throughput functional genomics using large circular (LC)-antisense molecules has been developed for the identification of genes associated with cancer cell growth (9) . The LC-antisense DNA of recombinant bacteriophages may result in advantages for higher chances of binding to complementary target cDNA, owing to its considerable length and high degree of sequence fidelity. LC-antisense DNA can be easily generated in a high-throughput and large-scale mode in transformed E. coli cultures.
In this study, we aimed to find the genes which are related to cancer cell growth using the LC-antisense library. We also investigated the possibility of using the identified antisense molecules as an adjuvant of conventional chemotherapeutic agents.
Materials and methods
Cell culture. Huh-7 were acquired from the Korean Cell Line Bank and cultured in DMEM containing 10% fetal bovine serum (Welgene, Daegu, Korea). The cultures were maintained at 37˚C in an atmosphere containing 5% CO 2 . Total RNA preparation was conducted with Welprep RNA isolation reagent (Welgene), in accordance with the protocol recommended by the manufacturer. The quality of purified RNA was verified from the OD 260/280 ratios and via electrophoresis using agarose gels stained with ethidium bromide.
Production of LC-antisense library.
A cancer-related plasmid set harboring human EST cDNA (Welgene), was utilized in the production of single-stranded phage genomic DNA harboring the antisense cDNA sequences. Clones for the antisense library were uni-directionally sub-cloned into the pBS SK (-) vector in order to produce the antisense sequence as a part of the phage genome (Fig. 1) . The recombinant phagemids were transformed into competent E. coli cells, XL-1 Blue (Stratagene, La Jolla, CA, USA), which had been infected with the helper bacteriophage, M13K07 (New England Biolabs, Ipswich, MA, USA). The transformed cells were then plated on LB agar plates containing ampicillin (50 μg/ml) and kanamycin (70 μg/ml) and incubated overnight at 37˚C. A single colony was carefully isolated and seeded in 100 ml of LB media (bactotryptone 10 g, yeast extract 5 g, NaCl 10 g/ 1000 ml, 50 μg/ml of ampicillin and 70 μg/ml of kanamycin). The cells were then cultured for 14 h at 37˚C, with constant agitation. After 10 min of centrifugation of the bacterial cells at 6,000 rpm at room temperature, 100 ml of the culture supernatant was mixed with 20 ml of Solution I (20% PEG 8000 + 2.5 M NaCl) and incubated for 10 min at room temperature. The column containing borosilicate filters was loaded with 50 ml of Solution II (4 M NaClO 4 , 50 mM Tris-HCl, pH 8.5) for both M13 lysis and binding and was incubated for 10 min at room temperature for the complete lysis of the bacteriophages. A vacuum was applied for 10 min in order to allow for the adsorption of the LC-antisense DNA into the filter. The column was then loaded with 100 ml of Solution III (80% EtOH, 20 mM NaCl, 2 mM Tris-HCl, pH 7.5) and a vacuum was applied for 10 min. The LCantisense DNA was then eluted using 10 ml of sterile water, precipitated with absolute ethanol and resuspended in sterile H 2 O.
Transfection of LC-antisense members to HCC cell line. In order to identify the genes involved in the growth of the liver cancer cells, Huh-7 cells were transfected with an LC-antisense library of 221 antisense members. The cells (3x10 3 ) were then seeded in each well of 96-well plates in 100 μl of DMEM media supplemented with 10% FBS. The cells were incubated for 12-18 h at 37˚C in a 5% CO 2 incubator. The LC-antisense library (0.1 μg) and control LC-antisense lacking an antisense insert were mixed with 0.3 μg of Enhancer Q and 0.5 μg of WelFect M (Welgene) and these complexes were then added to the cultured cells. The cultures were incubated for an additional 3 days. After transfection, microscopic observations and MTT assays were conducted in order to determine the effects of antisense molecules on the proliferation of cancer cells. The percentage of the inhibition of cell growth in each well treated with LC-antisense was calculated via the comparison of the optical density with those of the control treatments.
Real-time PCR for gene expression.
The relative gene expression levels were determined via real-time RT-PCR using SYBR-Green I. Total RNA (1 μg) was reversetranscribed using the random primers provided in the Reverse Transcription System (Promega, Madison, WI, USA). The cDNAs of the target genes were amplified using the DyNAmo HS SYBR-Green qPCR kit and the DNA Engine Opticon 2 System (MJ Research, Waltham, MA, USA), in accordance with the manufacturer's instructions. Used primer pairs were for AFP; forward 5'-ACTGAATCCAGAACACTGCATAG-3', reverse 5'-GCTTCTTGAACAAACTGGGCAAA-3', for EIF3EIP; forward 5'-TTGATGATGCGTCGTTACCAG-3', reverse 5'-CGCAACATCTTGTCCCCATATTT-3', and for human ß-actin; forward 5'-GAGCAAGAGAGGCATCCT CAC-3', reverse 5'-GATGGGCACAGTGTGGGTGAC-3'. The comparative threshold cycle method was utilized in order to quantify the target gene copy number within the Huh-7 RNA sample. In order to normalize the quantity of total RNA in each reaction, the ß-actin gene was simultaneously amplified. The PCR reactions were conducted in triplicate for each of the samples.
Fluorescence-activated cell sorting (FACS) analysis.
Huh-7 cells were washed once with PBS, followed by trypsinization and final resuspension in ice-cold PBS. Cell suspensions were fixed and permeabilized with ice-cold 70% ethanol. After treating the cells with 0.1 mg/ml RNase A (Sigma Chemical Co., St. Louis, MO, USA) at 37˚C for 10 min, DNA content was determined by staining with propidium iodide (Sigma Chemical Co.) at 0.01 mg/ml for 30 min. The cell cycle pattern was determined by flow cytometry using a FACScan flow cytometry system (Becton Dickinson, Franklin Lakes, NJ, USA).
Statistical analysis. The differences of gene expression levels between the groups and additive effects of LC-antisense with 5-FU were examined by using the Student's t-test.
Results

Functional analysis to validate genes involved in the growth of Huh-7 cells.
The LC-antisense library to the 221 unigene clone was constructed and utilized in the identification of genes functionally involved in the growth of HCC cells. LC-antisense molecules of 0.1 μg were complexed with cationic lipids and transfected into 2-3x10 3 Huh-7 cells in each well of 96-well plates. The cells were inspected for morphological changes via light microscopy ( Fig. 2 ) and quantitatively measured for growth inhibition via MTT assay, 3 days after transfection (Table I) . We determined that 37 out of the 221 members of the antisense library exerted a marked inhibitory effect on the growth of Huh-7. By way of contrast, cells treated with single-stranded control DNA (devoid of antisense insert sequences) showed a mild level of growth inhibition, which could also be seen in cells treated with the double-stranded DNA-lipid complex. The putative functional categorization of each gene was then conducted via motif-based searches, on the basis of the revealed sequence information (Table II) . These 37 genes appear to perform functions that are either directly or indirectly associated with the growth of HCC.
Effects of LC-antisense molecules to target gene expression.
The effects of LC-antisense were estimated to establish the potential of selected candidates. For example, LC-antisense to AFP (α-fetoprotein) and EIF3EIP (eukaryotic translation initiation factor 3, subunit E interacting protein) were selected. The relative expression levels of target genes were measured in Huh-7 cells treated with two LC-antisense molecules by real-time PCR. LC-antisense to EIF3EIP abolished the expression of EIF3EIP to the level of ~7% compared to the control or backbone treatment in Huh-7 cells. LC-antisense to AFP also decreased the expression level to ~39% of the control or backbone treatment (Fig. 3) . This result showed that two LC-antisense molecules successfully decreased the expression levels of target genes.
Additive effects of LC-antisense molecules on Huh-7 cell growth when combined with 5-FU.
To verify the ability of LC-antisense as adjuvant of cancer treatment, two LCantisense members to EIF3EIP and AFP were simultaneously treated with 5-FU to Huh-7 cells and the effect was determined by MTT cell survival assays (Fig. 4) . Two LCantisense molecules showed additive effects with 5-FU compared with 5-FU alone, respectively. Therefore, a lower ------------------------------------------------------------------------------------------------------ dose of 5-FU may be needed for the elimination of HCC in combination with the effective LC-antisense molecules.
----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------
Effects of LC-antisense molecules combined with 5-FU on cell cycle.
To know the effects of LC-antisense molecules combined with 5-FU on the cell cycle, cell cycle analysis was performed using a flow cytometer (Fig. 5) . Huh-7 cells treated with control DNA, 5-FU and 5-FU with LCantisense molecules were employed to study the cell cycle arrest. The combination of LC-antisense molecules and 5-FU showed a dramatic increase of sub-G1 apoptotic cell death fraction in cell cycle analysis, respectively.
Discussion
The RNA interfering technique is generally used for individual gene silencing. However, human diseases such as cancer are the result of accumulated alterations. Therefore, several recent studies were performed in massively parallel mode for the identification of genes related to cancer cell proliferation ONCOLOGY REPORTS 20: 905-911, 2008 Table II. The target genes for hepatocellular carcinoma selected by functional validation. 
(7,9-11). The LC-antisense molecule is a type of product using an RNA interfering mechanism and is already reported suitable in large-scale target search (9) . In this study, target validation using the 221 LC-antisense library showed that the inhibition of gene expression diminished the growth of liver cancer cells in 37 genes. Among these genes, it was reported that the expression of the TBX3 gene was increased in breast and ovarian cancer (12) and the inhibition of gene expression by siRNA to TBX3 showed growth inhibition (13) . It has recently been reported that the expression of another gene, AMOTL1, is related to angiogenesis and the clinical outcome of breast cancer (14) . It is well known that the expression of FABP1 (15) and CYP2E1 (16) is increased in HCC. Furthermore, antisense oligonucleotide to FABP was attempted to induce apoptosis of prostate cancer (17) . AFP is a well known marker of liver cancer and the inhibition of expression of AFP showed the growth inhibition of liver cancer cells (18, 19) . EIF3 is also reported as the target of cancer treatment (20) , though our results are the first from a study on the importance of EIF3EIP in the HCC cell line. However, ZBTB7C, known as APM-1 was reported as a candidate for the tumor suppressor gene (21) and SAMD9L was also reported to suppress the neoplastic phenotype (22) .
The reason for this discrepancy may be the result of off-target effects. However, more experiments using other methods such as siRNA and the verification of target gene inhibition are needed for a definite conclusion. In this study, LC-antisense molecules to AFP and EIF3EIP were chosen as examples for a further evaluation. The target gene inhibition of LC-antisense to AFP and EIF3EIP among 37 genes was confirmed by real-time PCR. LC-antisense molecules to AFP and EIF3EIP treatment potentiated the anticancer effect of 5-FU in the MTT assay and FACS analysis, so that the combination of 5-FU and these antisenses may be used for decreasing the side-effects of the cancer drug. These results mean that the selected genes using the LC-antisense library can be candidates of the anticancer drug target. All of the 37 selected genes will not be the absolute candidate of cancer target, though these results show the potential of this approach and more definite experiments on an individual target are required to find the potent target for the cancer drug or drug adjuvant. Many companies are involved in developing RNAi agents as potent inhibitors in various diseases. Preclinical cancer studies have shown the inhibition of growth and survival of tumor cells by RNAimediated downregulation of several key oncogenes or tumorpromoting genes (23, 24) , including growth and angiogenic factors or their receptors (25) and human telomerase (26) .
In conclusion, a target search for the treatment of HCC using LC-221 antisense members found 37 promising candidates in a high-throuput manner. From these candidates, LC-antisense to EIF3EIP and AFP showed additive effects of hepatocellular cancer cells when combined with conventional chemotherapeutics in MTT assay and cell cycle analysis. Therefore, these candidates may be used as target genes for drug development or adjuvant of conventional chemotherapeutic drugs.
